Factors associated with community use of adjuvant chemotherapy for stage III colon cancer - results from a national cohort study

被引：0
|
作者：
Jackson, C. [1 ]
Hinder, V. [2 ]
Sharples, K. [1 ,2 ]
Jeffery, M. [3 ]
Murray, M. [2 ]
Findlay, M. [2 ]
机构：
[1] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand
[2] Univ Auckland, Canc Trials New Zealand, Auckland 1, New Zealand
[3] Canterbury Reg Canc & Haematol Serv, Canterbury Dist Hlth Board, Christchurch, New Zealand
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31046-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2124
引用
收藏
页码：S372 / S373
页数：2
相关论文
共 50 条
  • [41] A NATIONAL EVALUATION OF THE USE AND SURVIVAL IMPACT OF ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER FROM THE NATIONAL CANCER DATABASE (NCBD).
    de Paula, T. Reif
    Haas, E.
    Simon, H. L.
    da Luz, M. M. Profeta
    Gorroochurn, P.
    Keller, D. S.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [42] A NATIONAL EVALUATION OF THE USE AND SURVIVAL IMPACT OF ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER FROM THE NATIONAL CANCER DATABASE (NCBD).
    de Paula, T. Reif
    Kiran, R. P.
    Simon, H. L.
    Profeta, M.
    Gorroochurn, P.
    Keller, D. S.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E397 - E398
  • [43] Lymph node yield and tumour subsite are associated with survival in stage I-III colon cancer: results from a national cohort study
    Lykke, Jakob
    Rosenberg, Jacob
    Jess, Per
    Roikjaer, Ole
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [44] The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study
    Sarfati, Diana
    Hill, Sarah
    Blakely, Tony
    Robson, Bridget
    Purdie, Gordon
    Dennett, Elizabeth
    Cormack, Donna
    Dew, Kevin
    BMC CANCER, 2009, 9
  • [45] The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study
    Diana Sarfati
    Sarah Hill
    Tony Blakely
    Bridget Robson
    Gordon Purdie
    Elizabeth Dennett
    Donna Cormack
    Kevin Dew
    BMC Cancer, 9
  • [46] NO TIME TO WAIT: FACTORS ASSOCIATED WITH DELAYED TIME TO ADJUVANT CHEMOTHERAPY AMONG STAGE III COLON CANCER PATIENTS.
    Becerra, A.
    Aquina, C.
    Tejani, M.
    Boscoe, F.
    Schymura, M.
    Noyes, K.
    Monson, J.
    Fleming, F.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E370 - E370
  • [47] Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study
    Ortiz-Ortiz, Karen J.
    Tortolero-Luna, Guillermo
    Rios-Motta, Ruth
    Veintidos-Feli, Alejandro
    Hunter-Mellado, Robert
    Torres-Cintron, Carlos R.
    Suarez-Ramos, Tonatiuh
    Magno, Priscilla
    PLOS ONE, 2018, 13 (03):
  • [48] Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study
    van den Broek, C. B. M.
    Puylaert, C. C. E. M.
    Breugom, A. J.
    Bastiaannet, E.
    de Craen, A. J. M.
    van de Velde, C. J. H.
    Liefers, G. -J.
    Portielje, J. E. A.
    COLORECTAL DISEASE, 2017, 19 (10) : O358 - O364
  • [49] Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study
    Boyle, Jemma M.
    Kuryba, Angela
    Cowling, Thomas E.
    van der Meulen, Jan
    Fearnhead, Nicola S.
    Walker, Kate
    Braun, Michael S.
    Aggarwal, Ajay
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 335 - 346
  • [50] Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
    Morris, M.
    Platell, C.
    Fritschi, L.
    Iacopetta, B.
    BRITISH JOURNAL OF CANCER, 2007, 96 (05) : 701 - 707
12345